FGF2 and cancer: In 1971, Folkman found that various growth factors such as VEGF and bFGF were continuously secreted by cancer cells to promote neovascularization and induce tumor proliferation, infiltration and metastasis, providing a theoretical basis for anti-angiogenesis in tumor therapy [16].